Background and Aims: Several treatment approaches exist for early stage hepatocellular carcinoma (HCC). We aimed to assess the benefits and harms of different treatment modalities for Barcelona Clinic Liver Cancer (BCLC) stage 0 (very early) and A (early) HCC by performing a network meta-analysis (NMA) using Cochrane methodology.
No takes yet. Share an insight, caveat, or question.
Majumdar et al. (2017) studied this question.